Table 1.
Median (range) | |
---|---|
Parameter | |
Total with racemose disease | 34 |
Active disease | 30 |
Inactive (calcified) disease | 4 |
Male (%) | 58.8 |
Hispanic (%) | 82.4 |
Travel related (%) | 5.9 |
Age parameters (years) | |
At enrollment, n = 34 | 37.9 (66–25) |
At diagnosis, n = 34 | 35.6 (16.4–66.2) |
At initial symptoms occurred, n = 34 | 29.7 (4–64.1) |
Patients who did not revisit endemic regions, n = 17 | 24.3 (7.7–46.2) |
At immigration, n = 30 | 24.5 (7.7–49.3) |
Time parameters (years) | |
Duration from immigration to symptoms (n = 27) | 10.0 (2–25.6) |
Patients who did not revisit endemic regions n = 17) | 10.0 (0.18–25.6) |
Duration of symptoms before immigration (n = 4) | −5.0 (2–9.5) |
Duration from immigration to diagnosis (n = 30) | 12.8 (1–33.6) |
Patients who did not revisit endemic regions (n = 22) | 10.3 (1–27.0) |
Duration followed up at the NIH | 5.3 (0.2–33.2) |
Duration from end of cysticidal treatment (n = 28) | 4.2 (0.2–18.1) |
Duration of disease since diagnosis, including follow-up* | 8.3 (0.01–39.9) |
* From diagnosis to last NIH visit.